Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sotera Health ( (SHC) ) has issued an announcement.
On March 4, 2026, Sotera Health Company and certain selling stockholders entered into an underwriting agreement with Wells Fargo Securities, LLC for the secondary sale of 25,000,000 shares of Sotera Health common stock at $15.270 per share. On March 6, 2026, the selling stockholders completed the sale of these shares to the underwriter, with the company itself issuing no new shares, receiving no proceeds from the transaction, and having no executive officers participate, underscoring that this deal reflects shareholder liquidity rather than a capital-raising move by Sotera Health.
The transaction may affect the trading dynamics and ownership structure of Sotera Health’s common stock, but it leaves the company’s balance sheet and direct capital position unchanged. Legal opinions confirming the validity of the shares were provided in connection with the offering, supporting the formal completion of this secondary sale by existing investors.
The most recent analyst rating on (SHC) stock is a Hold with a $17.50 price target. To see the full list of analyst forecasts on Sotera Health stock, see the SHC Stock Forecast page.
Spark’s Take on SHC Stock
According to Spark, TipRanks’ AI Analyst, SHC is a Neutral.
The score is held back mainly by balance-sheet leverage and weak technical momentum, with additional pressure from a high P/E and no dividend support. Offsetting factors include improving profitability/cash generation and a generally positive earnings call with clear 2026 growth and margin guidance plus ongoing deleveraging, though near-term softness, higher capex, and litigation risk temper upside.
To see Spark’s full report on SHC stock, click here.
More about Sotera Health
Sotera Health Company operates in the healthcare services sector, focusing on sterilization and lab testing solutions that support medical device and pharmaceutical manufacturers. The company’s offerings play a critical role in ensuring the safety and regulatory compliance of healthcare products used in global markets.
Average Trading Volume: 1,998,080
Technical Sentiment Signal: Sell
Current Market Cap: $4.28B
Find detailed analytics on SHC stock on TipRanks’ Stock Analysis page.